Global Plasmapheresis Machines Market Size By Type (Plasma Collection System, Multi-component Collection System), By Application (Extracorporeal Therapy, Plasma Donation), By Region, And Segment Forec...

The Global Plasmapheresis Machines Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 10.1% during the forecast period (2023–2031). The increasing prevalence of autoimmune and neurological disorders, rising demand for blood component separation procedures, and expanding plasma therapy applications are key drivers fueling market growth. Moreover, technological advancements in apheresis machines, rising investments in healthcare infrastructure, and the growing adoption of therapeutic plasma exchange are significantly contributing to the expansion of the plasmapheresis machines market globally.

Drivers:

1. Rising Prevalence of Autoimmune Diseases:

The increasing global incidence of autoimmune conditions such as multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome is driving the demand for plasmapheresis as a therapeutic intervention.

2. Expanding Applications in Plasma Therapy:

Plasma-derived therapies are gaining traction in treating various rare and chronic conditions, creating a significant need for plasmapheresis machines across healthcare facilities.

3. Technological Advancements in Apheresis Systems:

Modern plasmapheresis devices are now equipped with enhanced automation, improved safety features, and real-time monitoring capabilities, contributing to efficient and error-free procedures.

Restraints:

1. High Equipment and Maintenance Costs:

The initial investment for acquiring advanced plasmapheresis machines, along with maintenance and operational costs, can be a significant barrier, especially for healthcare centers in developing economies.

2. Limited Availability of Skilled Operators:

Operating plasmapheresis machines requires trained healthcare professionals. A shortage of skilled technicians in low- and middle-income countries is limiting market penetration.

Opportunity:

1. Growth in Emerging Economies:

Emerging healthcare markets in Asia-Pacific and Latin America are investing heavily in expanding their medical infrastructure, offering lucrative opportunities for market players to introduce cost-effective and efficient plasmapheresis solutions.

2. Rising Use in Neurological and Hematological Therapies:

Increasing research and successful clinical outcomes for using plasmapheresis in treating conditions like sickle cell disease and chronic inflammatory demyelinating polyneuropathy are opening new growth avenues.

Market by System Type Insights:

Based on system type, the Automated Plasmapheresis Machines segment held the largest market share in 2023. These machines offer precision, reduced procedure time, and minimal operator intervention. Their rising preference over manual systems due to improved efficiency and patient safety is driving segment growth. The Semi-Automated Machines segment, while smaller, is anticipated to grow steadily due to affordability and ease of use in mid-tier healthcare settings.

Market by End-use Insights:

In terms of end-use, Hospitals and Blood Donation Centers dominated the global market in 2023. These institutions are primary users of plasmapheresis machines for both therapeutic and donor-based plasma extraction. The Research Institutes and Academic Centers segment is also witnessing steady growth due to increased clinical trials and research activities in immunology and plasma-derived therapies.

Market by Regional Insights:

Geographically, North America held the largest market share in 2023, attributed to well-established healthcare systems, high awareness of plasmapheresis therapies, and the presence of leading manufacturers. Asia-Pacific is projected to witness the fastest growth during the forecast period, supported by expanding healthcare expenditure, increasing disease prevalence, and growing access to advanced therapeutic equipment.

Competitive Scenario:

Key players operating in the Global Plasmapheresis Machines Market include Terumo BCT, Haemonetics Corporation, Fresenius Kabi, Asahi Kasei Medical, Baxter International Inc., B. Braun Melsungen AG, Kawasumi Laboratories Inc., Cerus Corporation, and Nikkiso Co., Ltd. These companies are focusing on product innovations, regional expansion, strategic collaborations, and mergers & acquisitions to enhance their market presence and cater to rising global demand.

Scope of Work – Global Plasmapheresis Machines Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.4 billion

CAGR (2023–2031) 10.1%

Market Segments By System Type (Automated, Semi-Automated); By End-use (Hospitals & Blood Donation Centers, Research Institutes)

Growth Drivers Rising autoimmune disease burden, expanding plasma therapy applications, technological advancements

Opportunities Market expansion in Asia-Pacific and Latin America, increased use in hematological and neurological therapies

Key Market Developments:

2023: Haemonetics Corporation introduced a next-generation plasmapheresis system with enhanced donor safety features and reduced cycle times.

2024: Terumo BCT partnered with a leading hospital chain in India to deploy automated plasmapheresis machines across multiple tertiary care centers.

2025: Fresenius Kabi announced FDA clearance for its upgraded system featuring real-time plasma analytics and AI-assisted monitoring.

FAQs:

1) What is the current market size of the Global Plasmapheresis Machines Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Plasmapheresis Machines Market?

The major growth driver is the increasing prevalence of autoimmune and chronic neurological disorders.

3) Which is the largest region during the forecast period in the Global Plasmapheresis Machines Market?

North America is the largest region during the forecast period.

4) Which segment accounted for the largest market share in the Global Plasmapheresis Machines Market?

The Automated Plasmapheresis Machines segment accounted for the largest market share.

5) Who are the key market players in the Global Plasmapheresis Machines Market?

Key players include Terumo BCT, Haemonetics Corporation, Fresenius Kabi, Asahi Kasei Medical, and Baxter International Inc.